Akcea Therapeutics, Inc.
(AKCA)
Monteverde & Associates Announces the Investigation of Akcea Therapeutics, Inc.
Rosetta Stone Inc.
(RST)
Monteverde & Associates Announces the Investigation of Rosetta Stone Inc.
OncBioMune Pharmaceuticals, Inc.
(OBMP)
Monteverde & Associates Announces the Investigation of OncBioMune Pharmaceuticals, Inc.
Broadway Financial Corporation
(BYFC)
Monteverde & Associates Announces the Investigation of Broadway Financial Corporation
Proteostasis Therapeutics, Inc
(PTI)
Monteverde & Associates Announces the Investigation of Proteostasis Therapeutics, Inc
Cancer Genetics, Inc.
(CGIX)
Monteverde & Associates Announces the Investigation of Cancer Genetics, Inc.
Yintech Investment Holdings Limited
(YIN)
Monteverde & Associates Announces the Investigation of Yintech Investment Holdings Limited
Momenta Pharmaceuticals, Inc.
(MNTA)
Monteverde & Associates Announces the Investigation of Momenta Pharmaceuticals, Inc.
NTN Buzztime, Inc.
(NTN)
Monteverde & Associates Announces the Investigation of NTN Buzztime, Inc.
Churchill Capital Corp III
(CCXX)
Monteverde & Associates Announces the Investigation of Churchill Capital Corp III
Principia Biopharma Inc.
(PRNB)
Monteverde & Associates Announces the Investigation of Principia Biopharma Inc.
MVC Capital, Inc.
(MVC)
Monteverde & Associates Announces the Investigation of MVC Capital, Inc.
Cellular Biomedicine Group, Inc.
(CBMG)
Monteverde & Associates Announces the Investigation of Cellular Biomedicine Group, Inc.
Montage Resources Corporation
(MR)
Monteverde & Associates Announces the Investigation of Montage Resources Corporation
Net Element, Inc.
(NETE)
Monteverde & Associates Announces the Investigation of Net Element, Inc.
GCI Liberty, Inc.
(GLIBA)
Monteverde & Associates Announces the Investigation of GCI Liberty, Inc.
